A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura.
about
HITlights: a career perspective on heparin-induced thrombocytopeniaPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaMeasurement of endogenous and exogenous alpha-granular platelet proteins in patients with immune and nonimmune thrombocytopenia.Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients.The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review.Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.Historical aspects and present knowledge of idiopathic thrombocytopenic purpura.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP).Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatment.Adult idiopathic thrombocytopenic purpura.Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors.Fetal hydrocephalus in a pregnancy complicated by idiopathic thrombocytopenic purpura.A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Determination of platelet-bound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia.Increased number of B-cells in the red pulp of the spleen in ITP.The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia.The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.A blinded study of bone marrow examinations in patients with primary immune thrombocytopeniaSustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonistsValue of vanin-1 assessment in adult patients with primary immune thrombocytopenia.FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.Detection of circulating B cells producing anti-GPIb autoantibodies in patients with immune thrombocytopeniaImmune thrombocytopenia: recent progress in pathophysiology and treatment.Novel treatments for immune thrombocytopenia.Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatmentAntibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.State of the art - how I manage immune thrombocytopenia.The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused PatientsEffects of cytotoxin-associated gene A (CagA) positive Helicobacter pylori infection on anti-platelet glycoprotein antibody producing B cells in patients with primary idiopathic thrombocytopenic purpura (ITP).Rituximab therapy in pemphigus and other autoantibody-mediated diseases.Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab.Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancer.
P2860
Q26828351-6C4A992E-B4B8-441A-95B2-A91F0ADC354BQ27024841-4F7B184B-138F-4E09-A614-D6A47B293915Q33329902-82F5EF8A-2894-40A1-8970-19AB9BFFD2CBQ33339731-877538CF-271A-4C23-8B39-7B32E659526CQ33342281-ADEFAE0A-7C6B-4C08-904D-BDFD4ECBA02AQ33343948-426080AF-3CFE-4234-8A84-5E653D7A5EE1Q33345598-EA5CCBFD-E835-4A0E-8089-22242D2C757BQ33346561-50E4612D-F094-474C-AAD4-9105ED213DC4Q33349084-AEF8068D-277A-44F2-949F-5F13FC2F5942Q33349710-D5E4E6DA-3957-4C30-AAAB-1EBC0F453548Q33358032-89FF5C7B-C1D4-4AC7-A274-412745AB5012Q33364418-9653EB10-764B-4B24-BD3D-D008CB29A838Q33371359-B3E57657-EDA1-4B9D-8817-2E8351CECFE8Q33373279-CC901B1C-0B39-4B23-B205-8647D404F917Q33390656-ADB8B75B-5523-4F9D-90C3-2E5B854C4DB0Q33392868-9CF31AB4-82A9-4674-89D4-5D48DCD883A7Q33393474-C5B5D562-F2C8-4E7B-8030-8EBD914099DDQ33396338-97BA1A5D-67DB-4612-AAC3-81603E8926DCQ33396360-29FDD098-CEE3-44E0-BBD5-25FABC757521Q33399688-43032557-E3E1-4EBA-90C5-F2945AFAE2D4Q33403270-39DFF68F-B554-4A9A-8D3A-9A8DF1838D6EQ33404293-951B1DD7-E76A-42B8-9EE2-EE3B831D4743Q33406176-5BAB369A-B277-4BD2-955C-BAF85877C28EQ33406674-B75A12AC-CEFF-4EBA-BA54-534194EF5D2FQ33406804-20AD0DC6-8AC3-455A-8BC4-657C77E7CEDFQ33409515-BD663502-DB52-4252-B940-40E558139E6AQ33412917-7EDB65EE-80FE-48B7-81C2-F9150876D3E3Q33413896-FF8D41C0-790D-4D7F-A386-9F4532150577Q33414132-F4EA19D1-48E4-4C30-9DEB-5C86BB490B9EQ33417357-E738EFFB-5960-4145-B386-9C2CDE8E8E9DQ33420459-5CABB968-B267-4D03-AA2D-A7BB6BF9922FQ33423336-40274CEB-D12A-4D94-8316-72015CD80C9AQ33440145-D26F6F1E-3AE8-4094-B68C-77C598376125Q33441391-3D2BE84E-63C3-4D12-9195-0F7ACB3EB688Q33442354-825AE5A6-3416-4749-B979-F5919BA908ACQ34766786-BEF7BE41-81B7-401A-8E3D-DEB210DF1AD4Q35277427-CDAF1224-0BEF-43C9-AE1A-E1C622178A46Q37620483-2822362E-8332-4927-A902-22A4F15C2482Q40575535-77AA1853-DDAB-4192-9BD6-1010F677FA37Q41851571-BE04718C-3926-40FD-9F58-375527BDE1A7
P2860
A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A prospective study of protein ...... thic thrombocytopenic purpura.
@ast
A prospective study of protein ...... thic thrombocytopenic purpura.
@en
A prospective study of protein ...... thic thrombocytopenic purpura.
@nl
type
label
A prospective study of protein ...... thic thrombocytopenic purpura.
@ast
A prospective study of protein ...... thic thrombocytopenic purpura.
@en
A prospective study of protein ...... thic thrombocytopenic purpura.
@nl
prefLabel
A prospective study of protein ...... thic thrombocytopenic purpura.
@ast
A prospective study of protein ...... thic thrombocytopenic purpura.
@en
A prospective study of protein ...... thic thrombocytopenic purpura.
@nl
P2093
P1476
A prospective study of protein ...... thic thrombocytopenic purpura.
@en
P2093
P304
P356
10.1046/J.1365-2141.1999.01218.X
P407
P577
1999-03-01T00:00:00Z